Duncan Williams Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$954K Buy
2,634
+2
+0.1% +$685 0.22% 66
2026
Q1
$926K Buy
2,632
+3
+0.1% +$1.07K 0.26% 59
2025
Q4
$963K Buy
2,629
+3
+0.1% +$952 0.24% 65
2025
Q3
$741K Buy
2,626
+4
+0.2% +$1.16K 0.21% 78
2025
Q2
$732K Buy
2,622
+3
+0.1% +$850 0.23% 68
2025
Q1
$816K Hold
2,619
0.29% 60
2024
Q4
$683K Buy
2,619
+324
+14% +$96.1K 0.27% 70
2024
Q3
$740K Buy
2,295
+219
+11% +$71.6K 0.41% 48
2024
Q2
$649K Buy
2,076
+1
+0% +$294 0.55% 33
2024
Q1
$590K Buy
+2,075
New +$607K 0.53% 32

Other funds holding AMGN

Duncan Williams Asset Management's AMGN Position: Q2 2026 in Review

Duncan Williams Asset Management increased its Amgen (AMGN) stake by 0.08% in Q2 2026, buying an estimated $685 and bringing the position to 2,634 shares worth $954K. The position accounts for 0.22% of the portfolio, ranked #66.

Duncan Williams Asset Management first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $963K in Q4 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Duncan Williams Asset Management held 2,634 shares of Amgen worth $954K as of Q2 2026.
  • Duncan Williams Asset Management bought 2 Amgen shares in Q2 2026, an estimated $685.
  • Amgen made up 0.22% of Duncan Williams Asset Management's portfolio in Q2 2026, its #66 holding.
  • Duncan Williams Asset Management first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • Duncan Williams Asset Management's Amgen position peaked at $963K in Q4 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Duncan Williams Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.